retatrutide death Demand for Unapproved Weight-Loss Drug Surges on Social Media Triple hormone receptor agonist retatrutide

Saxenda Saxenda is a GLP-1 receptor agonist similar to Ozempic and Wegovy but is specifically approved for weight loss in individuals with obesity

Hierdoor bespaar je direct kostbare voorbereidingstijd in het laboratorium

[DOI] [PMC free article] [PubMed] [Google Scholar] 86.Steinberg G.R., Hardie D.G

For a detailed explanation of what GLP-1 is and how these medications promote weight loss, read our article on what GLP-1 is and how it supports appetite and metabolic health

Our physicians may prescribe medications, help you set diet and exercise goals, and monitor your weight loss progress

potential FDA submission 2028 (estimated): Possible FDA approval and commercial availability In the meantime, FDA-approved weight loss medications are available now